Mutations in N-ras predominate in acute myeloid leukemia.
Using synthetic oligomers we investigated fresh samples of acute myeloid leukemia (AML) for the presence of mutated ras oncogenes. Our original results showed that five of eight samples contained a mutation in codon 13 of the N-ras gene. In a subsequent study involving 37 samples, we found only one N-ras-13 mutation, and, in addition, mutations in codon 61 of the N-ras gene in four cases and a mutation in codon 12 of the Ki-ras gene in two cases. Amplification of ras genes was not observed. We conclude that in approximately 20% to 25% of AML cases, a mutated ras oncogene is present, predominantly the N-ras gene. The occurrence of mutations does not correlate with the cytological features of the leukemia.
D001483:Base Sequence; D002874:Chromosome Mapping; D004273:DNA, Neoplasm / Q000235:genetics; D019204:GTP-Binding Proteins / Q000235:genetics*; D005784:Gene Amplification; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000235:genetics*; D009154:Mutation; D009857:Oncogenes
D004273:DNA, Neoplasm; D019204:GTP-Binding Proteins